These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2129250)

  • 1. [Structure and characteristics of singer chain urokinase-type plasminogen activator].
    Shi W; Zhang CY
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):314-7. PubMed ID: 2129250
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator.
    Ploug M; Behrendt N; Løber D; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):183-93. PubMed ID: 1665583
    [No Abstract]   [Full Text] [Related]  

  • 3. The urokinase-type plasminogen activator receptor is a member of the Ly-6 superfamily.
    Palfree RG
    Immunol Today; 1991 May; 12(5):170. PubMed ID: 1652256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of thrombolytic enzymes].
    Matsuo O
    Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasminogen activators as thrombolytic agents in myocardial infarction].
    Chamone DA; Massumoto C; Fujimura AY; Pileggi F; Bellotti G
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(6):288-94. PubMed ID: 2518605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasminogen activators. Genes and proteins structure.
    Blasi F; Riccio A; Sebastio G
    Horiz Biochem Biophys; 1986; 8():377-414. PubMed ID: 3093360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
    Arimura H; Kasai S; Nishida M; Suyama T
    Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639
    [No Abstract]   [Full Text] [Related]  

  • 8. Domain structure and interactions of plasminogen activators.
    Medved LV; Novokhatny VV; Ingham KC
    Ukr Biokhim Zh (1978); 1996; 68(4):39-40. PubMed ID: 9226825
    [No Abstract]   [Full Text] [Related]  

  • 9. The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis.
    Beal MF
    Exp Neurol; 2008 Jun; 211(2):332-3. PubMed ID: 18423450
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The structure and function of urokinase receptor and its expression in neoplastic tissues].
    Tang H; Zhu Y; Song H
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):315-7. PubMed ID: 7656166
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inactivation and stabilization of urokinase fibrinolytic activity in vitro].
    Aĭsina RB; Mukhametova LI; Sazonova IIu; Varfolomeev SD
    Bioorg Khim; 1998 Jul; 24(7):544-8. PubMed ID: 9749317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and plasmin in lung cancer.
    Maksimowicz T; Gacko M; Chyczewska E; Chyczewski L; Myćko G; Worowski K
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():72-8. PubMed ID: 9337525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Effect of induced chronic intravascular coagulation on plasminogen activator in dogs.
    Owen CA
    Thromb Diath Haemorrh; 1975 Sep; 34(1):309-11. PubMed ID: 1188714
    [No Abstract]   [Full Text] [Related]  

  • 20. Urokinase-dependent cell surface proteolysis and cancer.
    Blasi F; Verde P
    Semin Cancer Biol; 1990 Apr; 1(2):117-26. PubMed ID: 2151734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.